Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Allied Corp

Healthcare US ALID

0.0005USD
0.00(0%)

Last update at 2026-06-23T20:00:00Z

Day Range

0.010.01
LowHigh

52 Week Range

0.00050.02
LowHigh

Fundamentals

  • Previous Close 0.0005
  • Market Cap0.06M
  • Volume285
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-2.54041M
  • Revenue TTM0.10M
  • Revenue Per Share TTM0.001
  • Gross Profit TTM -0.32656M
  • Diluted EPS TTM-0.04

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-08-31 2023-08-31 2022-08-31 2021-08-31 2020-08-31
Type yearly yearly yearly yearly yearly
Date 2024-08-31 2023-08-31 2022-08-31 2021-08-31 2020-08-31
Income before tax -3.97618M -10.67567M -15.53885M -11.48525M -6.60776M
Minority interest - - - - -
Net income -3.97618M -10.67567M -15.53885M -11.48525M -6.60776M
Selling general administrative 1.87M 5.22M 14.25M 2.18M 2.82M
Selling and marketing expenses - - - - -
Gross profit -0.32313M -1.46177M 0.07M -0.62547M -
Reconciled depreciation 0.14M 0.14M 0.08M 0.55M 0.47M
Ebit - - -14.30589M -11.48525M -3.62870M
Ebitda - - -14.22191M -10.31234M -5.99348M
Depreciation and amortization - - - - -
Non operating income net other - - - -3.84130M -
Operating income -2.83904M -6.83101M -14.30954M -7.64395M -3.28592M
Other operating expenses - - - 3.22M -
Interest expense 0.85M 0.86M 1.23M 0.63M 0.15M
Tax provision - - - - -
Interest income - - - - -
Net interest income -0.84887M -0.86320M -1.23436M -1.28018M -0.37555M
Extraordinary items - - - - -
Non recurring - - - 1.60M -
Other items - - - - -
Income tax expense - - - - -
Total revenue 0.10M 0.07M 0.17M 0.01M 0.00000M
Total operating expenses 2.94M 6.90M 14.48M 7.66M 3.29M
Cost of revenue 0.42M 1.53M 0.09M 0.64M -
Total other income expense net -0.28828M -2.98146M 0.00504M -3.21218M -2.94629M
Discontinued operations - - - - -
Net income from continuing ops -3.97618M -10.67567M -15.53885M -11.48525M -6.60776M
Net income applicable to common shares - - -15.53885M -11.48525M -6.60776M
Preferred stock and other adjustments - - - - -
Breakdown 2024-08-31 2023-08-31 2022-08-31 2021-08-31 2020-08-31
Type yearly yearly yearly yearly yearly
Date 2024-08-31 2023-08-31 2022-08-31 2021-08-31 2020-08-31
Total assets 2.11M 2.06M 5.79M 4.63M 7.10M
Intangible assets 0.03M 0.04M 0.19M 0.05M 3.30M
Earning assets - - - - -
Other current assets - - - 3.99M -
Total liab 9.66M 8.95M 7.07M 5.60M 3.40M
Total stockholder equity -7.54846M -6.88446M -1.28240M -0.97078M 3.70M
Deferred long term liab - - - - -
Other current liab - - 0.09M 0.03M 0.54M
Common stock - - 0.00940M 0.00799M 0.00851M
Capital stock 0.01M 0.01M 0.00940M 0.00799M 0.00851M
Retained earnings -49.58452M -45.60834M -34.93267M -19.39381M -7.90857M
Other liab - - - - -
Good will - - - - -
Other assets - - 2.87M 3.16M 3.01M
Cash 0.36M 0.21M 0.10M 0.42M 0.09M
Cash and equivalents - - - - -
Total current liabilities 9.55M 8.85M 6.91M 5.38M 3.07M
Current deferred revenue - - - - -
Net debt 6.12M 5.54M 4.79M 3.07M 1.56M
Short term debt - - - 3.49M -
Short long term debt 6.47M 5.75M 4.89M 3.49M 1.65M
Short long term debt total - - - - -
Other stockholder equity - - -0.35822M 0.32M -0.62216M
Property plant equipment - - 1.63M 0.52M 0.60M
Total current assets 0.71M 0.47M 1.24M 0.92M 0.20M
Long term investments - - - - -
Net tangible assets - - -1.32717M -0.97078M 0.40M
Short term investments - - - - -
Net receivables 0.05M - 0.12M 0.08M -
Long term debt - - - - -
Inventory 0.26M 0.11M 1.00M 0.14M 0.05M
Accounts payable 0.83M 2.39M 0.79M 1.87M 0.79M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - 0.00799M -
Preferred stock total equity - - - - -
Retained earnings total equity - - - -19.39381M -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 1.40M 1.59M 4.55M 3.72M 6.91M
Capital lease obligations 0.13M 0.11M 0.19M 0.25M 0.35M
Long term debt total - - - - -
Breakdown 2024-08-31 2023-08-31 2022-08-31 2021-08-31 2020-08-31
Type yearly yearly yearly yearly yearly
Date 2024-08-31 2023-08-31 2022-08-31 2021-08-31 2020-08-31
Investments -0.00989M -0.08779M -1.20537M -0.27491M -1.82060M
Change to liabilities - - -0.21558M 0.45M 0.16M
Total cashflows from investing activities - - -1.20537M -0.27491M -1.82060M
Net borrowings 0.22M - 0.91M 1.93M 1.64M
Total cash from financing activities 2.16M 2.07M 5.33M 4.62M 4.02M
Change to operating activities - - 0.49M 0.00605M -0.14452M
Net income -3.97618M -10.67567M -15.53885M -11.48525M -6.60776M
Change in cash 0.15M 0.02M -0.32378M 0.38M -0.98684M
Begin period cash flow 0.21M 0.10M 0.42M 0.09M 1.08M
End period cash flow 0.36M 0.21M 0.10M 0.42M 0.09M
Total cash from operating activities -2.00030M -1.95678M -4.28427M -3.95626M -3.16080M
Issuance of capital stock 1.94M 1.53M 3.88M 1.76M 2.38M
Depreciation 0.14M 0.14M 0.08M 1.20M 0.47M
Other cashflows from investing activities - - - 0.17M 0.13M
Dividends paid - - - - -
Change to inventory -0.07682M -0.44717M -0.78754M 0.55M -0.05258M
Change to account receivables 0.09M 0.21M -0.03859M -0.08284M -0.08284M
Sale purchase of stock - - - 2.68M -
Other cashflows from financing activities - - - - -
Change to netincome - - 11.72M 5.72M 3.01M
Capital expenditures 0.00989M 0.09M 1.19M 0.22M 1.83M
Change receivables - - - -0.08284M -
Cash flows other operating - - - 0.79M -
Exchange rate changes - - - -0.05915M -
Cash and cash equivalents changes - - - 0.38M -
Change in working capital 0.49M 0.13M -0.54967M -0.22126M -0.03360M
Stock based compensation 0.50M 3.05M 7.32M 2.67M -
Other non cash items 0.85M 1.01M 4.37M 0.85M 0.76M
Free cash flow -2.01019M -2.04457M -5.48963M -4.18011M -3.27236M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ALID
Allied Corp		 - -% 0.0005 - - 0.55 52.50 62.70 -6.1729
ZTS
Zoetis Inc		 1.03 1.34% 77.87 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR		 0.83 2.69% 31.72 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 - -% 155.71 21.73 14.95 3.16 2.15 3.56 12.82
GALDY
GALDERMA GROUP AG		 1.49 3.43% 44.91 74.21 41.67 8.64 5.55 9.15 42.22

Reports Covered

Stock Research & News

View All

Profile

Allied Corp., a cannabis company, develops, manufactures, and markets hemp derived cannabis products in the United States. The company operates in two segments, Allied Colombia and Allied Corp. It offers hemp-based CBD natural health products, as well as cannabis related products, including beauty and skincare products, and foods and beverages. The company also develops ALID 10 and ALID 11 for the treatment of post-traumatic stress disorder and related mental health conditions through the targeted function of the 5-HT2 receptor and physiological pathways. Allied Corp. is headquartered in Kelowna, Canada

Allied Corp

460 Doyle Ave, Kelowna, BC, Canada, V1Y OC2

Key Executives

Name Title Year Born
Mr. Calum Hughes Founder, Chairman & CEO NA
Mr. Ryan Marschaalk B.Sc., C.P.A. Chief Financial Officer NA
Mr. Paul Bullock COO & Director NA
Mr. James Smeeding M.B.A., MBA, R.Ph., RPh VP of Pharmaceuticals Devel. & Director 1950
Mr. James R. McMillan Chief Commercial Officer of Consumer Packaged Goods 1968
Dr. Radka Milanova Ph.D. Chief Scientific Director NA
Mr. Michael Moses Chief Executive Officer NA
Mr. Paul Bullock COO, Interim CFO & Director NA
Mr. Tim Levy Head of Cultivation NA
Mr. Mark Moses Chief of Staff NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions